|
|
||||||||
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Ga 30333, USA.
To evaluate reporting sensitivities for vaccine adverse events, reporting rates were estimated by dividing the number of events reported to the Monitoring System for Adverse Events Following Immunization and the Vaccine Adverse Event Reporting System in a given period by the number of doses administered or distributed during the same period. Reporting sensitivity was calculated as the ratio of the rates at which events were reported to each passive surveillance system (numerator) and occurred in controlled studies (denominator). Reporting sensitivities were generally better in the public sector than in the private sector. The significant underreporting of known outcomes, together with the nonspecific nature of most adverse event reports, highlights the limitations of passive surveillance systems in assessing the incidence of vaccine adverse events.
This article has been cited by other articles:
![]() |
V. L. Hinrichsen, B. Kruskal, M. A. O'Brien, T. A. Lieu, R. Platt, and Vaccine Safety Datalink Team Using Electronic Medical Records to Enhance Detection and Reporting of Vaccine Adverse Events J. Am. Med. Inform. Assoc., November 1, 2007; 14(6): 731 - 735. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Mahoney, D. J. Sargent, M. J. O'Connell, R. M. Goldberg, P. Schaefer, and J. C. Buckner Dealing With a Deluge of Data: An Assessment of Adverse Event Data on North Central Cancer Treatment Group Trials J. Clin. Oncol., December 20, 2005; 23(36): 9275 - 9281. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Izurieta, P. Haber, R. P. Wise, J. Iskander, D. Pratt, C. Mink, S. Chang, M. M. Braun, and R. Ball Adverse Events Reported Following Live, Cold-Adapted, Intranasal Influenza Vaccine JAMA, December 7, 2005; 294(21): 2720 - 2725. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Casey, J. K. Iskander, M. H. Roper, E. E. Mast, X.-J. Wen, T. J. Torok, L. E. Chapman, D. L. Swerdlow, J. Morgan, J. D. Heffelfinger, et al. Adverse Events Associated With Smallpox Vaccination in the United States, January-October 2003 JAMA, December 7, 2005; 294(21): 2734 - 2743. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. McMahon, J. Iskander, P. Haber, S. Chang, E. J. Woo, M. M. Braun, and R. Ball Adverse Events After Inactivated Influenza Vaccination Among Children Less Than 2 Years of Age: Analysis of Reports From the Vaccine Adverse Event Reporting System, 1990-2003 Pediatrics, February 1, 2005; 115(2): 453 - 460. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Haber, F. DeStefano, F. J. Angulo, J. Iskander, S. V. Shadomy, E. Weintraub, and R. T. Chen Guillain-Barre Syndrome Following Influenza Vaccination JAMA, November 24, 2004; 292(20): 2478 - 2481. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Wise, J. Iskander, R. D. Pratt, S. Campbell, R. Ball, R. P. Pless, and M. M. Braun Postlicensure Safety Surveillance for 7-Valent Pneumococcal Conjugate Vaccine JAMA, October 13, 2004; 292(14): 1702 - 1710. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Parker, B. Schwartz, J. Todd, and L. K. Pickering Thimerosal-Containing Vaccines and Autistic Spectrum Disorder: A Critical Review of Published Original Data Pediatrics, September 1, 2004; 114(3): 793 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Haber, R. T. Chen, L. R. Zanardi, G. T. Mootrey, R. English, M. M. Braun, and the VAERS Working Group An Analysis of Rotavirus Vaccine Reports to the Vaccine Adverse Event Reporting System: More Than Intussusception Alone? Pediatrics, April 1, 2004; 113(4): e353 - e359. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Pool, M. M. Braun, J. M. Kelso, G. Mootrey, R. T. Chen, J. W. Yunginger, R. M. Jacobson, and P. M. Gargiullo Prevalence of Anti-Gelatin IgE Antibodies in People With Anaphylaxis After Measles-Mumps-Rubella Vaccine in the United States Pediatrics, December 1, 2002; 110(6): e71 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
Adverse Events Associated With 17D-Derived Yellow Fever Vaccination--United States, 2001-2002 JAMA, November 27, 2002; 288(20): 2533 - 2535. [Full Text] [PDF] |
||||
![]() |
D M Salisbury, P C L Beverley, and E Miller Vaccine programmes and policies Br. Med. Bull., July 1, 2002; 62(1): 201 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Verstraeten, A. L. Baughman, B. Cadwell, L. Zanardi, P. Haber, R. T. Chen, and the Vaccine Adverse Event Reporting System Team Enhancing Vaccine Safety Surveillance: A Capture-Recapture Analysis of Intussusception after Rotavirus Vaccination Am. J. Epidemiol., December 1, 2001; 154(11): 1006 - 1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Zanardi, P. Haber, G. T. Mootrey, M. T. Niu, M. Wharton, and the VAERS Working Group Intussusception Among Recipients of Rotavirus Vaccine: Reports to the Vaccine Adverse Event Reporting System Pediatrics, June 1, 2001; 107(6): e97 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Wattigney, G. T. Mootrey, M. M. Braun, and R. T. Chen Surveillance for Poliovirus Vaccine Adverse Events, 1991 to 1998: Impact of a Sequential Vaccination Schedule of Inactivated Poliovirus Vaccine Followed by Oral Poliovirus Vaccine Pediatrics, May 1, 2001; 107(5): 83e - 83. [Abstract] [Full Text] |
||||
![]() |
T. S. DuVernoy, M. M. Braun, and the VAERS Working Group Hypotonic-Hyporesponsive Episodes Reported to the Vaccine Adverse Event Reporting System (VAERS), 1996-1998 Pediatrics, October 1, 2000; 106(4): 52e - 52. [Abstract] [Full Text] |
||||
![]() |
M. M. Braun, G. Terracciano, M. E. Salive, D. A. Blumberg, P. E. Vermeer-de Bondt, H. Heijbel, G. Evans, P. A. Patriarca, and S. S. Ellenberg Report of a US Public Health Service Workshop on Hypotonic-Hyporesponsive Episode (HHE) After Pertussis Immunization Pediatrics, November 1, 1998; 102(5): 52e - 52. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |